{"id":"W2019089983","doi":"10.1158/0008-5472.sabcs-09-5114","title":"Pertuzumab and Trastuzumab: Re-Responses to 2 Biological Agents in Patients with HER2-Positive Breast Cancer Which Had Previously Progressed during Therapy with Each Agent Given Separately: A New Biological and Clinical Observation.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation; BC Cancer Agency; Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Oncology; Internal medicine; Cohort; Metastatic breast cancer; Breast cancer; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001691376,0.0003286031,0.0005832707,0.0002511015,0.0002169032,0.000486863,0.0003704927,0.0006925242,0.0007944665],"category_scores_gemma":[0.002630709,0.0001384426,0.0006164393,0.0002223822,0.0002200006,0.0004662884,0.0002315047,0.0007958873,0.0001981763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005635982,"about_ca_system_score_gemma":0.0002863633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000271007,"about_ca_topic_score_gemma":0.0004293451,"domain_scores_codex":[0.999167,0.0003642392,0.00009475369,0.0001246187,0.000163857,0.00008543352],"domain_scores_gemma":[0.9987726,0.0004505374,0.0003101076,0.00009694698,0.0001265537,0.0002431793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1190457,0.004536877,0.4620773,0.0005827157,0.001274034,0.003605944,0.0006461077,0.0007181214,0.03688497,0.0002099526,0.003687281,0.3667311],"study_design_scores_gemma":[0.009260694,0.1156168,0.811798,0.0001262358,0.001418178,0.01511805,0.0002570139,0.00201633,0.0256564,0.0002000176,0.01845309,0.00007903984],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937561,0.004625029,0.0002159942,0.000216923,0.00004633017,0.00009210973,0.000103364,0.00001600899,0.0009281681],"genre_scores_gemma":[0.9969286,0.001129888,0.0004245146,0.0002474017,0.0001598261,0.00007704621,0.00045651,0.000003987911,0.0005721901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001691376,"threshold_uncertainty_score":0.008944929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.228070954439714,"score_gpt":0.4791410790961227,"score_spread":0.2510701246564087,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}